AnnMarie Nagelin

Title: AnnMarie Nagelin: Innovator in Immune Response Modulation

Introduction

AnnMarie Nagelin is a prominent inventor based in Saugus, MA (US). She has made significant contributions to the field of immunology, particularly in the area of type I diabetes. Her innovative work focuses on methods to downmodulate immune responses, which can have profound implications for autoimmune diseases.

Latest Patents

AnnMarie Nagelin holds a patent for a "Method for downmodulating immune response in type I diabetes." This invention provides compositions and methods for the downmodulation of immune responses, specifically targeting autoimmune responses. The methods involve using agents that block CD28-mediated signaling, which are useful for both prophylactic and therapeutic applications in managing immune responses.

Career Highlights

Throughout her career, AnnMarie has been associated with Genetics Institute, Inc., where she has been able to apply her expertise in immunology. Her work has been instrumental in advancing the understanding of immune response modulation, particularly in the context of type I diabetes.

Collaborations

One of her notable collaborators is Richard O'Hara, Jr. Together, they have worked on various projects aimed at enhancing the efficacy of immune response modulation techniques.

Conclusion

AnnMarie Nagelin's contributions to the field of immunology, particularly through her patent on downmodulating immune responses, highlight her role as an innovator in this critical area of research. Her work continues to pave the way for new therapeutic strategies in managing autoimmune diseases.